It remains a mystery how PDC-E2 and other epitopes localized to the inner membrane of mitochondria become targets of autoimmune injury in PBC. One working hypothesis, largely enforced by the Gershwin group, is that modifications of 2-OADC by xenobiotics may alter these self-proteins to cause a breakdown of tolerance facilitating an autoimmune response.